about
BARD1 induces apoptosis by catalysing phosphorylation of p53 by DNA-damage response kinaseRobotic Surgery in GynecologyConcise Review: Methods and Cell Types Used to Generate Down Syndrome Induced Pluripotent Stem CellsOvarian Drilling in PCOS: Is it Really Useful?Human pluripotent stem cells differentiated in fully defined medium generate hematopoietic CD34- and CD34+ progenitors with distinct characteristicsIdentification of BARD1 as mediator between proapoptotic stress and p53-dependent apoptosisBARD1 expression during spermatogenesis is associated with apoptosis and hormonally regulatedGranulocytic Sarcoma Presenting as a Palpable Breast Lump.Data in brief: Transcriptome analysis of induced pluripotent stem cells from monozygotic twins discordant for trisomy 21.A teratocarcinoma-like human embryonic stem cell (hESC) line and four hESC lines reveal potentially oncogenic genomic changesTwo case reports of a malignant germ cell tumor of ovary and a granulosa cell tumor: interest of tumoral immunochemistry in the identification and management.An effective serum- and xeno-free chemically defined freezing procedure for human embryonic and induced pluripotent stem cellsEndometriosis and infertility: how and when to treat?Endometriosis: a new cellular and molecular genetic approach for understanding the pathogenesis and evolutivityLaparoscopic management of interstitial pregnancy and fertility outcomes after ipsilateral salpingectomy - three case reports.Placental site trophoblastic tumor: a case report and review of the literatureLaparoscopic treatment of placenta percreta retention in a cesarean scar: a case report.Gynecology and Obstetrics has Entered Modern Times: Perspectives and Challenges.The secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factorDNA-Methylation Patterns in Trisomy 21 Using Cells from Monozygotic TwinsEndometriosis and Vesico-Sphincteral Disorders.Mutational spectrum of p53 mutations in primary breast and ovarian tumors.Human pluripotent stem cells: applications and challenges in neurological diseases.Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage.Identification of displaced endometrial glands and embryonic duct remnants in female fetal reproductive tract: possible pathogenetic role in endometriotic and pelvic neoplastic processesA Case Report: Pseudoangiomatous Stromal Hyperplasia Tumor Presenting as a Palpable Mass.Verrucous Carcinoma of the Vulva: A Case Report and Review of the LiteratureXeno-free derivation and culture of human embryonic stem cells: current status, problems and challenges.Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21.Molecular mechanisms of pluripotency and reprogramming.Dental pulp stem cells, niches, and notch signaling in tooth injury.European view of subspecialty training on behalf of the European Society of Human Reproduction and Embryology (ESHRE).Antimicrobial activity and cytotoxicity of 3 photosensitizers activated with blue light."XXIst century odyssey of Medicine" stem cells and their future.The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity.Xeno-free culture of human pluripotent stem cells.Immortalized human skin fibroblast feeder cells support growth and maintenance of both human embryonic and induced pluripotent stem cells.Derivation of the first Swiss human embryonic stem cell line from a single blastomere of an arrested four-cell stage embryo.[Preservation of women fertility facing potential premature ovarian failure].22q11 Deletion Syndrome and Urogenital Manifestations: A Clinicopathological Case Report.
P50
Q24298631-073FAFE4-DC6B-4E5D-9A7B-3034D5A1780DQ26747236-45D1E87C-195F-41F1-B25B-5A337A94CE39Q26799570-65704061-52CC-4D02-AB1F-5EFD754E130AQ26799852-921E73B6-A035-4079-A5FA-3D9ED6246779Q27314152-E99D2A38-197D-4E04-A9E0-52F24C6D57CDQ28214712-3CB98A64-44DD-4577-B1FF-BFFBECF62B80Q28581513-0EDB5318-4943-4FD4-83F6-761C2736DD5DQ30363976-287EEDE2-EAD1-438E-8A9F-35F6ACE19F77Q31008411-A8B8A070-1DFE-42A4-95EE-0B9382B1B59FQ33567638-88DE9B9A-CABB-4DBB-81AE-86D87B1B052FQ33749386-39AB8049-619E-4D77-97EC-C7CD7D3BED18Q33787107-4A850373-EF87-420C-A9E2-E70DC253B89CQ34867801-F1EBCA4D-1CD7-476A-907D-3CCD2A4111E7Q34867977-5A1C350D-64AA-4AA4-98BD-62D8525A0295Q34868076-7E7415C6-0459-4C27-A7A7-6FD987D2F433Q34868128-D37A4B75-44B1-415F-8561-D02907A5E0B4Q34868268-3CD6463B-4096-4AF0-871F-79166A43FBD8Q34868356-7BC92056-A3B5-465E-A685-0ABB68E677B4Q35654823-8BCFB648-A317-42F0-8B2C-E0FA4E2F8752Q35758454-72BB8875-EA99-450E-8B57-67BE04D7E2ECQ35765239-0A7ADCD1-B0B9-4DBD-8F6C-62AEE76EEE3AQ35925963-C3B70693-0949-462D-A1AA-D6F4E6DFCF78Q36193696-74419978-A0F8-462C-82A6-D8D7E3C365E1Q36266493-5DA323E2-5948-4DAA-86D7-0F3CF3A248DFQ36439719-1EE18F75-DE7F-42F7-AA6D-5C7DAF01151CQ36475328-D552705D-9674-4F9F-8FF9-A06E839888FFQ36568716-847683AC-8C11-417E-AD3A-B06B8575344CQ36898638-40B2378E-35C6-4F35-AC53-87D7B79CBACCQ37591118-3395D178-220C-4343-B7AE-7D873E803686Q37802928-308A0ACE-40BF-43D7-B87D-E61CEA9F10E1Q37890160-F2EF1D26-2066-40EA-8021-4AD5472FCCEDQ38519174-DF3BDC70-E871-4118-9405-A78F0BE90363Q39021290-EB9F3E27-5BED-432E-9C29-15A53045AA5AQ39346246-098827C4-B909-4F09-A221-CE59D19646ECQ39382468-A887EE47-8AA1-4894-8511-D79629C48BD9Q39493648-04B784AD-4488-46F6-8300-7087BA12E305Q39833141-AB95BF54-EAE0-4E4B-8A1C-4700D29C2D1FQ39938102-D15E74CC-AC6E-4D61-AE87-CC1745CEDA69Q41610848-776F9F38-3F88-45D9-BCB4-53F56470662CQ41892718-AC62448D-7BD6-4DB6-BDBA-09958042B9A9
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anis Feki
@ast
Anis Feki
@en
Anis Feki
@es
Anis Feki
@nl
type
label
Anis Feki
@ast
Anis Feki
@en
Anis Feki
@es
Anis Feki
@nl
prefLabel
Anis Feki
@ast
Anis Feki
@en
Anis Feki
@es
Anis Feki
@nl
P106
P31
P496
0000-0002-9817-9445